TOJACIA10S (Tofacitinib (10mg))

Tojacia 10mg Tablet is indicated for the management of moderate to severe cases of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. The medication works by alleviating pain, tenderness, and joint swelling through its anti-inflammatory properties. Additionally, it plays a role in slowing the deterioration of bone and joint structure. This tablet can be utilized alone or in conjunction with other treatments. It is recommended to take the tablet consistently, either with food or on an empty stomach, ideally at the same time each day. The dosage will be tailored based on the patient’s specific condition and any other medications being used. It is crucial to follow the prescribing doctor’s instructions and not to discontinue usage without medical guidance, as this could exacerbate the condition. Patients may experience side effects, with common ones including upper respiratory infections, headaches, diarrhea, and nasopharyngitis. There are also rarer but more serious effects, such as blood clots and intestinal or stomach wall perforations, which require immediate medical care. Prior to starting Tojacia, blood tests may be necessary, and the medication should not be commenced during any active infection. Patients should consult their physician if they have a history of conditions like tuberculosis, shingles, liver or kidney diseases, hepatitis, or blood clots. Tojacia is not recommended for individuals under 18 years of age, and use during pregnancy or breastfeeding should only occur if the healthcare provider deems the benefits to outweigh potential risks. Regular medical evaluations may be required during treatment.